Not Signed In - Pediatric Amoxicillin PULSYS Phase III Trial
Sun, 24 Apr 2005 06:00 PM EST
... AdvancisPharmaceutical Corporation (Nasdaq: AVNC), a pharmaceutical company focused ondeveloping and commercializing novel anti-infective products, today announcedthat it has completed enrollment ahead of schedule in the Company's pediatricAmoxicillin PULSYS Phase III clinical trial for the treatment ofpharyngitis/tonsillitis due to Group A streptococcal infections... click link for more info. ...
Related Topics
- Clinical Trials
- Amoxicillin
- Children's Health
- Antithrombin III
- Pediatric Care
- Pediatric Aids
- Familial Dysautonomia
- Lansoprazole, Clarithromycin and Amoxicillin
- Amoxicillin and Clavulanate Potassium
- Food Recommendations: South Beach Diet - Phase 1
- Food Recommendations: South Beach Diet - Phase 2
- Autoimmune Disorders
- Congenital antithrombin III deficiency
- Cranial mononeuropathy III - compression type
- Cranial mononeuropathy III - diabetic type
- Antithrombin
- Crohn's Disease
- Didanosine Pediatric Oral Solution
- Osteogenesis imperfecta, type III
- Asthma - pediatric
email this page
print this page
bookmark this page
feedback on this page
